Wilentz Promotes Four Associates to Shareholders

4.11.2017

Wilentz, Goldman & Spitzer, P.A. announced today that Daniel Kluska, Satish Poondi and Karin Sage have been promoted to Shareholder and Vincent Cheng to Counsel. All reside in the firm’s Woodbridge, NJ office.

“We are pleased to promote these outstanding litigators,” said Brian J. Molloy, President and Managing Director of Wilentz. “We continue to deepen our bench as part of our commitment to providing clients with the highest level of service.”

Commercial Litigation

Daniel Kluska is a shareholder in Wilentz’s Commercial Litigation practice. He represents owners, builders and developers in actions arising out of the construction of numerous types of real estate projects, often involving claims of construction and design defects, project-related misrepresentations and alleged breaches of warranty. Mr. Kluska also represents law firms of all sizes at both the trial and appellate review level in malpractice and related matters.

Karin Sage is a shareholder in Wilentz’s Commercial Litigation practice. She manages litigation in New Jersey state and federal courts for large corporations and small to mid-sized law firms in matters concerning fiduciary duties, legal malpractice defense, shareholder derivative actions, contracts, fraud, and estate/probate litigation. Ms. Sage serves on the District Ethics Committee of the New Jersey Supreme Court and as a Trustee of the Ocean County Bar Association. 

Mass Torts

Satish Poondi is a legal advisor and registered pharmacist in Wilentz’s Mass Tort Litigation practice. Mr. Poondi’s credentials in law and pharmacy enable him to provide his clients with a uniquely informed approach to the issues they confront both legally and with respect to science. Mr. Poondi represents clients in the pharmacy and healthcare sectors. He also provides regulatory advice with respect to the sale and purchase of pharmacies. 

Vincent Cheng is counsel in Wilentz's Mass Tort Litigation practice, where he manages personal injury cases, including those arising from asbestos exposure.